Manufacturer: Abnova Corporation
Pack Size | SKU | Availability | Price |
---|---|---|---|
Each of 1 | 89-933-826-Each-of-1 | In Stock | ₹ 64,426.68 |
89-933-826 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 64,426.68
GST (18%): ₹ 11,596.802
Total Price: ₹ 76,023.482
CD45RA
Monoclonal
Unconjugated
Flow Cytometry (0.5-1 ug/million cells in 0.1 mL) Immunofluorescence (1-2 ug/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (0.5-1 ug/mL) The optimal working dilution should be determined by the end user.
B220/CD45/CD45R/GP180/LCA/LY5/T200
Mouse
Protein A/G purification
RUO
5788
Human
Liquid
Flow Cytometry, Immunofluorescence, Immunohistochemistry (PFA fixed)
PTPRC/818
Mouse monoclonal antibody raised against full length recombinant human CD45RA.
In 10mM PBS (0.05% BSA, 0.05% sodium azide).
PTPRC
Recombinant protein corresponding to full length of human CD45RA.
100 μg
Primary
Recognizes a protein of 205kDa-220kDa, identified as CD45RA. CD45RA is isoforms of the human leukocyte common antigen (CD45). Human CD45 contains three exons which encode peptide segments designated A, B and C, respectively. The differential splicing of the exons generates at least five isoforms, ABC, AB, BC, B and O. This antibody reacts with ABC and BC isoforms. CD45RA is expressed on 40-50% of peripheral CD4+ T-cells, 50% of peripheral CD8+ T-cells, B-cells, and leukemic B-cell lines. T-cells expressing CD45RA are naive or virgin T-cells. T-cells expressing CD45RO are memory T-cells. CD45RA and CD45RO define complementary, predominantly non-overlapping populations of resting peripheral T-cells. This antibody is useful in study on the subpopulation of CD4+ or CD8+ T-cells. It can especially be used to differentiate T-cell lymphomas (CD45RO +ve) from B cell lymphomas (CD45RA +ve).
Store at 4°C.
IgG2a κ